Skip to main content
TipRanks
Go Ultimate75% OFF

Carclo plc (C1Y) AI Stock Analysis

1 Followers
DE:C1Y

Carclo plc

(Frankfurt:C1Y)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Improved profitability and capital returnsThe sharp improvement in operating margin and return on capital indicates that the turnaround is translating into more productive use of assets and stronger underlying economics. Sustaining these gains would improve earnings quality, support internal investment, and strengthen competitiveness over the next several quarters.
Negative Factors
Negative equity and elevated leverageNegative shareholders’ equity leaves Carclo with a thin financial buffer and makes the business more sensitive to earnings volatility. Although debt has fallen from earlier levels, sizable borrowings alongside negative equity preserve refinancing risk and restrict flexibility for acquisitions or downturns.

Carclo plc (C1Y) vs. iShares MSCI Germany ETF (EWG)

-60%-50%-40%-30%-20%-10%0%10%20%DE:C1Y-39.74%EWG+6.88%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 29.37M
Dividend Yield
―
Average Volume (3M)
341
Price to Earnings (P/E)
10.5
Beta (1Y)
1.02
Revenue Growth
-8.31%
EPS Growth
193.06%
Country
Germany
Employees
907
Sector
Consumer Cyclical
Sector Strength
61
Industry
Manufacturing - Miscellaneous

Carclo plc Business Overview & Revenue Model

Company Description

Carclo plc, along with its subsidiaries, operates as a global manufacturing entity primarily focused on producing and distributing high-precision, injection-molded plastic components. The company's business activities are structured into two key divi...

Carclo plc Earnings Call Summary

Earnings Call Date:Jul 01, 2026(Q4-2026)|% Change Since:21.76%|Next Earnings Date:Jan 21, 2020
Earnings Call SentimentPositive

The call emphasized a successful multi-year turnaround: stronger margins, improved returns, better safety and sustainability metrics, robust Specialty growth and a completed refinancing that provides stability. Management set clear Precision 2030 targets and is already ahead on return metrics. Near-term headwinds include deliberate revenue reduction from portfolio exits, ongoing pension deficit contributions, net debt still above target (1.3x EBITDA), no dividend and mixed demand in parts of Life Sciences driven by a weak respiratory virus season. On balance, operational and financial improvements are substantial and management has a concrete plan to address remaining issues.

Positive Updates

Improved Profitability and Margins
Operating profit margin increased to 11% (management target >=10%), reflecting sustained margin improvement through self-help activities, improved materials management and better asset utilization.

Negative Updates

Reported Revenue Decline
Reported revenue fell year-on-year. Decline was largely deliberate due to portfolio exits and stopping lower-margin short-run business; FX translation reduced revenue by around GBP 2.6m and H1 FY25 included GBP 2.2m of exited products.

Company Guidance

Management guidance under Precision 2030 targets organic revenue compounding above 8%, net debt below 0.5x EBITDA by end‑FY'31, return on sales at/above 10% and return on capital at/above 25%; trading is expected to be H2‑weighted with positive organic revenue for the year and bolt‑on acquisitions treated as upside to the base plan. The board cites FY'22–FY'26 progress as validation: operating margin/return on sales up to 11% (from <5%), ROCE >29% (from 9.5%), net debt/EBITDA down to 1.3x (from 2.5x), cash from operations up to £12m (from <£7m), Specialty revenue CAGR 14% and strategic manufacturing CAGR 4%, while safety incidents fell ~75% (2.7→0.7 per 100,000 hours) and carbon intensity per £1m revenue more than halved. They reiterated the refinancing completed, the agreed pension recovery plan of £3.5m p.a. for the next four years (plus a one‑off £5.1m contribution made), pension cash costs now ~19% of underlying EBITDA (vs ~30% previously), and an expectation that structural tax and financing drags will unwind as profitability and financing costs improve.

Carclo plc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:C1Y against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:CTAGB:CTA66NeutralGBP 16.56M3.4820.83%―4.04%-25.71%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
GB:TRTGB:TRT53NeutralGBP 5.94M-57.25-1.47%―-16.65%-107.46%
GB:AUTGGB:AUTG43NeutralGBP 4.91M30.001.81%―-9.41%―
GB:STGGB:STG42NeutralGBP 4.10M-2.13617.63%―7.23%45.60%

* Consumer Cyclical Sector Average

Performance Comparison

-50%0%50%DE:C1YGB:AUTGGB:TRTGB:CTAGB:STGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:C1Y and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:C1YCarclo plc0.47-0.23-33.33%
GB:AUTGAutins Group plc9.00-1.50-14.29%
GB:TRTTransense Technologies PLC39.50-78.00-66.38%
GB:CTACT Automotive Group Plc23.00-10.00-30.30%
GB:STGStrip Tinning Holdings plc22.50-5.00-18.18%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.